VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy

nork Hilmi, Caroline, Guyot, Mélanie, Pagès, Gilles
Argitaratua 2012

The ELR(+)CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma

nork Giuliano, Sandy, Guyot, Mélanie, Grépin, Renaud, Pagès, Gilles
Argitaratua 2014

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies

nork Guyot, Mélanie, Hilmi, Caroline, Ambrosetti, Damien, Merlano, Marco, Nigro, Cristiana Lo, Durivault, Jérôme, Grépin, Renaud, Pagès, Gilles
Argitaratua izan da Oncotarget (2016)

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR recepto...

nork Grépin, Renaud, Guyot, Mélanie, Dumond, Aurore, Durivault, Jérôme, Ambrosetti, Damien, Roussel, Jean-François, Dupré, Florence, Quintens, Hervé, Pagès, Gilles
Argitaratua izan da Theranostics (2020)

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

nork Dufies, Maeva, Giuliano, Sandy, Viotti, Julien, Borchiellini, Delphine, Cooley, Linsay S, Ambrosetti, Damien, Guyot, Mélanie, Ndiaye, Papa Diogop, Parola, Julien, Claren, Audrey, Schiappa, Renaud, Gal, Jocelyn, Frangeul, Antoine, Jacquel, Arnaud, Cassuto, Ophélie, Grépin, Renaud, Auberger, Patrick, Bikfalvi, Andréas, Milano, Gérard, Escudier, Bernard, Rioux-Leclercq, Nathalie, Porta, Camillo, Negrier, Sylvie, Chamorey, Emmanuel, Ferrero, Jean-Marc, Pagès, Gilles
Argitaratua izan da Br J Cancer (2017)